AtriCure target price raised to $62 from $36
ATRC•J.P. Morgan raised its target price for AtriCure to $62 from $36.
Related News
Xometry raises target price to $117 from $100
XMTR•
RBC cuts Ideaya Biosciences target price to $45 from $48
IDYA•
Oppenheimer raises Amgen target price to $520 from $480
AMGN•
Sands China publishes listing document for $1 billion senior debt offering
LVS•
HealthStream, Inc.: Canaccord Genuity raises target price to $32 from $29
HSTM•